Publications of J. Breu

Deussing, J. M.; Breu, J.; Kühne, C.; Kallnik, M.; Bunck, M.; Glasl, L.; Yen, Y. C.; Schmidt, M. V.; Zurmühlen, R.; Vogl, A. M. et al.; Gailus-Durner, V.; Fuchs, H.; Hölter, S. M.; Wotjak, C. T.; Landgraf, R.; de Angelis, M. H.; Holsboer, F.; Wurst, W.: Urocortin 3 Modulates Social Discrimination Abilities via Corticotropin-Releasing Hormone Receptor Type 2. Journal of Neuroscience 30 (27), pp. 9103 - 9116 (2010)

Deussing, J. M.; Kuhne, C.; Pütz, B.; Panhuysen, M.; Breu, J.; Stenzel-Poore, M. P.; Holsboer, F.; Wurst, W.: Expression profiling identifies the CRH/CRH-R1 system as a modulator of neurovascular gene activity. Journal of Cerebral Blood Flow and Metabolism 27 (8), pp. 1476 - 1495 (2007)

Breu, J.; Deussing, J. M.; Wurst, W.: CRHR-1 signalling inhibits AMPA-receptor internalisation. Pharmacopsychiatry 38 (5), p. 232 - 232 (2005)

Deussing, J. M.; Kühne, C.; Panhuysen, M.; Pütz, B.; Breu, J.; Paez-Pereda, M.; Holsboer, F.; Wurst, W.: Gene expression profiling reveals corticotropin-releasing hormone (CRH) dependent signaling pathways. Pharmacopsychiatry 38 (5), p. 236 - 236 (2005)

Deussing, J.; Breu, J.; Binder, E. B.; Ohl, F.; Holsboer, F.; Wurst, W.: Addressing in vivo functions of urocortin III, a novel member of the CRH family of neuropeptides. Pharmacopsychiatry 36 (5), p. 221 - 221 (2003)

Bender, J.; Ederer, M. S.; Breu, J.; Engeholm, M.; Michalakis, S.; Wurst, W.; Deussing, J. M.: Clustering of corticotropin-releasing hormone receptor type 1 with membrane-associated guanylate kinases. In EUROPEAN NEUROPSYCHOPHARMACOLOGY, 25 (Supplement 1), P.1.006, pp. S8 - S9. ECNP Workshop for Junior Scientists in Europe, Nice, FRANCE, March 12, 2015 - March 15, 2015. Elsevier Science BV, Amsterdam, NL (2015)